Neurogene Inc. (NGNE)
NASDAQ·Healthcare·Biotechnology
$31.12
+6.01%
Mkt Cap $459.83M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
Implied Upside
+121.8%
Consensus $69.00 vs current $31.12
NASDAQ·Healthcare·Biotechnology
$31.12
+6.01%
Mkt Cap $459.83M
Buy
3
Hold
0
Sell
0
Price Target (13 analysts)
$69.00
Range $69.00 – $69.00
+121.8%
Consensus $69.00 vs current $31.12